Why the study?
Does actinomycin D inhibit the replication of human coronavirus 229E in L132 cells?
Population
L132 cells infected with human coronavirus 229E
Comparison
Actinomycin D vs Untreated control cells (no drug)
Design
Preclinical
Follow-up
up to 48 hours post-infection
Authors
Loading...
Actinomycin D may inhibit early HCoV-229E replication in vitro; leaves open host-factor requirements for coronaviruses in vivo.
Does actinomycin D inhibit the replication of human coronavirus 229E in L132 cells?
Actinomycin D inhibits the early stages of human coronavirus 229E replication in L132 cells, suggesting a requirement for a limiting unstable host product.
Kennedy et al. (1979) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: